Remote technology has quickly become a critical element of clinical trials. According to a June 2021 survey from WCG, 94% of research sites expect to use at least one form of remote technology in the ...

The second half of 2022 brought the first gene therapies for hemophilia to the market in both the United States and abroad. The second half of 2022 brought the first gene therapies for hemophilia to ...

Phase I trials often represent the first occasion where new cancer strategies are tested in patients. Various developments in cancer biology, methodology, regulation, and medical ethics have altered ...

With the recent advances in cell reprogramming, scientists can take a mature human cell — such as a skin cell — and revert it ...

The ethical considerations associated with generative AI are diverse and vast. Research about AI ethics is emerging at a precipitous pace. Thus, the goal of this resource is to provide a succinct ...

Oriel Zagazeta is a biology major with a chemistry minor and is a 2022-23 health care ethics intern at the Markkula Center for Applied Ethics. Views are his own. The use of stem cells in health care ...

Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508 In contrast to clinical biopsies, where tissue is collected to ...

Can human beings cure all diseases in our lifetime? For centuries, humanity has strived to cure diseases. With the advent of Artificial Intelligence (AI), the dream of a disease-free world seems more ...

April 19 (UPI) --A chatbot turns hostile. A test version of a Roomba vacuum collects images of users in private situations. A Black woman is falsely identified as a suspect on the basis of facial ...